Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy

Lung cancer is currently the leading cause of cancer-related deaths worldwide. Significant improvements in lung cancer therapeutics have relied on a better understanding of lung cancer immunity and the development of novel immunotherapies, as best exemplified by the introduction of PD-1/PD-L1-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoden, Bettina, DeRubeis, David, Martinez-Moczygemba, Margarita, Ramos, Kenneth S., Zhang, Dekai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659925/
https://www.ncbi.nlm.nih.gov/pubmed/36389785
http://dx.doi.org/10.3389/fimmu.2022.1033483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659925/
https://www.ncbi.nlm.nih.gov/pubmed/36389785
http://dx.doi.org/10.3389/fimmu.2022.1033483

Ejemplares similares